Introduction
From a biomedical perspective, risk is understood as the objective and evidence-based risk of an adverse outcome when performing any diagnostic or therapeutic procedure [1, 2] . Comprehensive research based on this approach to risk provides important knowledge on risks related to conventional treatments. Up to now, comparatively little research has investigated patients' individual risk perceptions. This fact can be linked to the established scientific understanding of risk as an objective phenomenon. In recent risk research it has been argued that there is a significant problem with using 'objective' epidemiological risk assessment because risk is reduced to a statistical measure that does not take into account patients' attitudes or risk-taking behaviors [3] . A hermeneutic understanding of risk as a social construct including uncertainty and subjective elements has thus been introduced [3] [4] [5] [6] [7] . The particular interpretation of risk has a significant influence on how it is handled. Experts and lay persons may disagree about existing risks because they understand risk differently and have different worldviews, experiences, and education [6] [7] [8] [9] [10] . This argumentation may be especially relevant in approaching risks associated with patients' use of complementary and alternative medicine (CAM), as CAM use is often unregulated, based on lay knowledge, and initiated by patients themselves or by unauthorized CAM practitioners [7] .
CAM and Risk
This study explored risk perceptions among a sample of Norwegian CAM users diagnosed with cancer or multiple sclerosis (MS) and their doctors. The Norwegian Act No. 64 of 27 June 2003 [11] defines CAM as '(…) health-related treatment which is practiced outside the established health services and which is not practiced by authorized health personnel. Treatment performed inside the health service or by health personnel is included by the concept alternative medicine when methods that normally are practiced outside the health service are used. ' Approximately 50% of Norwegian cancer and MS patients use CAM [12, 13] . Despite the widespread use, studies on risks associated with the use of CAM still remain sparse, and a need for more research that enables patients to make informed treatment decisions has been emphasized by several authors [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . The existing literature shows that benefits and low risk are associated with some specific CAM treatments used by MS and cancer patients when implemented properly [e.g., 14-16, 19, 25-27] , while other treatments are considered unsafe or ineffective [e.g., [14] [15] [16] 18] . In general, increased CAM use has been interpreted as a result of both a positive attitude toward CAM and a somewhat negative attitude toward conventional health care. From the patient perspective, the use of CAM can induce benefits that lead to new health practices [14-17, 19, 28-30] . Patients' negative attitudes toward conventional medicine can be linked to adverse effects of treatments, lack of conventional treatment options for a particular medical problem, or lack of trust in conventional care [17-19, 24, 28-30] . CAM users seem to base their treatment decisions on lay constructions of a therapeutic pluralism that includes both scientific medical knowledge and embodied and experience-based knowledge [7, 17, [28] [29] [30] . Thus, there may be unexplored gaps between CAM users' and doctors' perceptions of risk. Such possible differences represent an important and under-investigated aspect of decision-making, communication, and patient safety in contemporary health care.
Aims, Risk Definition, and Research Questions
The purpose of this study was to explore doctors' and cancer and MS patients' perceptions of risks associated with the use of CAM and conventional medicine. The study was based on a sociocultural understanding of risk as a situation or event where something of human value is at stake, and where there is uncertainty about the potential for and occurrence of unwanted negative consequences of the event. The research questions addressed were:
1. How do CAM users diagnosed with cancer or MS perceive risks associated with conventional medicine and CAM?
2. How do doctors perceive such risks? 3. Are there differences in patients' and doctors' risk perceptions? If so, how can these differences be interpreted?
The study is part of a larger qualitative study on cancer and MS patients' position between conventional medicine and CAM [28] [29] [30] .
Material and Methods
Participants were selected via the Registry of Exceptional Courses of Disease (hereafter 'the Registry'), which includes Scandinavian self-reported positive and negative courses of disease related to the use of CAM [31, 32] . In this study, patients with cancer or MS were included because both patient groups are large, and their use of CAM is widespread and considered as potentially risky [12, 13, [20] [21] [22] [23] [24] . Exceptional cases are deviant cases that can illustrate unusual and typical aspects of a phenomenon and be perceived as illuminative and rich in information [33] [34] [35] . The Registry contains information on patients representing different commitment to CAM and various experiences from the use of CAM and conventional medicine. It also contains medical records and contact information for the patients' doctors and CAM practitioners [31, 35] . Such a sample of CAM users and health care providers is time-consuming and challenging to establish, and the Registry can represent a rather unique possibility for idiographic sampling [36] of qualitative studies on different aspects of CAM as viewed from different stakeholders' perspectives.
Patients
As of December 31, 2008, 52 cancer patients (41 women, 11 men) and 58 MS patients (39 women, 19 men) were registered. Based on a document analysis of the Registry material entailing these 110 cases (a questionnaire, medical records, etc.), possible participants were selected. Specific differences with respect to gender or country were not identified. 13 Norwegian cancer patients (12 women, 1 man) and 12 Norwegian MS patients (9 women, 3 men) were included. Inclusion continued until a small amount of new information was obtained during interviews and redundancy occurred. The data obtained was then deemed to be sufficient [37] .
The cancer patients' age ranged from 38 to 84 years, 7 of whom had a higher education. The mean time since diagnosis was 9.2 years. The diagnoses were breast cancer (7), Hodgkin's lymphoma (2), prostate cancer (1), and ovarian cancer (1). The last 2 patients had rare cancer diagnoses that are not listed in order to avoid identification. Nutritional therapy, spiritual healing, and acupuncture were the CAM modalities most frequently used. 6 patients used conventional and alternative therapies simultaneously through their entire cancer treatment, while 6 discontinued or refused conventional cancer treatment at some stage after surgery. 1 patient refused all conventional treatment.
The MS patients ranged in age from 39 to 55, 10 of whom had a higher education. The number of years since being diagnosed with MS varied from 6 to 21. The distribution of MS subtypes [38] was relapsing remitting (3), secondary progressive (6), and primary progressive (3). Acupuncture, nutritional therapy, homeopathy, and spiritual healing were the CAM modalities most frequently used. 3 used alternative treatments exclusively.
Doctors
From 2009 to 2010, 15 doctors (5 oncologists, 5 neurologists, 5 general practitioners) who had treated 19 of the 25 patients in the study were invited to participate. All but 1 oncologist and 2 neurologists accepted. All participants (6 women, 6 men) had a Western medical education. They ranged in age between 41 and 65 and worked within the Norwegian conventional health care system where they had been practicing for more than 10 years. 2 general practitioners were also experienced CAM practitioners.
Qualitative Interviews
Qualitative interviews were the primary source of information, perceived as interactional, reciprocal, and reflexive processes [39] , and directed toward understanding the participants' perspectives on their experiences, perceptions, or situations [40] . The patient interviews focused personal history, experiences with conventional care and/or CAM, and reasons for the use of CAM. They were performed face-to-face by the author and a research assistant in a 90-to 150-min time frame, and took place at the patients' homes or another location chosen by the participant.
The doctors were interviewed with the aim of gaining an understanding of their perspectives in general, not regarding their experiences with patients in this study in particular. The main issues concerned experiences with patients' CAM use, risk perceptions associated with conventional medicine and CAM, and doctor-patient communication. 6 doctors were interviewed in their offices, 1 at home, and 5 by telephone. These interviews took between 45 and 90 min. All 37 interviews were audio-recorded and transcribed verbatim by a professional transcriptionist.
Analysis
Qualitative content analysis and the systematic classification process of coding and identifying different themes or patterns were used to interpret the data [41] . In a first evaluation step, the patient interviews were studied intensively to gain a general understanding of the main investigated issues. In a second step, they were re-evaluated and coded in NVivo 8 qualitative software, starting with line-by-line coding of ideas, themes, and concepts. Afterwards, secondary substantive codes were developed summarizing key concepts across the data [41] . 'Patients' and doctors' differing risk perceptions' was identified as an important empirical pattern in the patient material. The same procedure was followed when analyzing the interviews with doctors. 'Differences in risk perceptions' was also highlighted by the doctors and therefore extracted as main pattern.
Ethical Considerations
The study was conducted according to the Declaration of Helsinki [42] . The Regional Committee for Medical and Health Research Ethics and the Norwegian Data Protection Authority approved the Registry and the research project. The patients gave written consent to participate. The transcriptionist signed a written consent to professional confidentiality. The interviews were conducted with sensitivity toward the needs and abilities of each participant [43] .
Results

Patients' Risk Perceptions
The patients differed in diagnosis, but their perceptions of risk were in general very similar. One difference was that the cancer patients had been offered a variety of conventional treatments while some of the MS patients had been offered only very limited conventional treatment options. The patients had made great efforts to create a knowledge basis for their treatment decisions by reading medical and CAM literature as well as talking to doctors, CAM practitioners, and persons in their social networks about treatment options and experiences.
Conventional treatment was perceived as a considerable health risk by many patients in both disease groups. For the cancer patients, this was often based on their experiences of dramatic, fatal cancer courses and substandard medical care in their families. They expressed that, e.g., 'the adverse effects of chemotherapy and radiation were frightening' and 'the treatment entailed so much suffering to no avail.' Also several MS patients had experienced severe adverse effects from conventional treatments, such as β-interferon and cortisone, before they decided to use CAM. Further, patients perceived conventional treatments as potential health risks based on what they had learned from their doctors about adverse effects. They often found it difficult to understand their 'personal risk' against the background of risk statistics based on clinical cases and described personal cost-benefit assessments with regard to conventional treatment and risk. A cancer patient stated that 'after reading up on what radiation does to the body, and looking at all the adverse effects versus the benefits when it comes to my diagnosis, I chose to decline.' Some patients were experienced conventional health care providers themselves. They used their professional knowledge combined with knowledge about CAM when they made their risk assessments and treatment decisions. A nurse who had cancer and declined all conventional treatment explained: 'I had faith that there are many roads to Rome. Most people having had similar operations experience severe adverse effects. I did not want to poison the body with chemotherapy and radiation. I had good reason (based on knowledge of conventional and alternative treatment options) to believe that I could reach a better goal without the conventional treatment that was offered, and I have reached that goal. ' The patient perspectives on risks associated with conventional medicine and their experiences with doctor-patient communication about this topic strongly influenced their decision to use CAM. Most of them combined conventional and alternative treatment and often used CAM to strengthen their benefit from conventional methods. Many used CAM to cope better with their disease and to increase quality of life. In general, they described CAM as 'safe', 'natural', and 'without adverse effects'. None described negative effects of CAM use experienced by themselves or significant others. From the media, they knew about patients who had negative experiences with CAM practitioners, CAM products, and the economic burden of using CAM. However, they did not identify with these CAM users because they trusted in their choice of therapies and practitioners. Many patients stated that they 'owed themselves' to try out alternatives to conventional treatment because, as explained by a cancer patient, 'at least, it wouldn't hurt me to try, whereas not to try could turn out as a really bad decision when I wanted to live a good life with my cancer and maybe even could get cured'. CAM therapies were often evaluated based on bodily experiences, as a kind of 'bodily risk assessment'. CAM represented something 'positive' and 'harmless' that the patients themselves could do to strengthen their health by actively taking part in treatment decisions and healing processes.
Doctors' Risk Perceptions
The doctors were specialized in different fields of medicine, 2 of them also in CAM. Despite their different competences, they had a common understanding of risk as the evidence-based risk of an adverse outcome connected to specific treatments and diagnoses. Oncologists had more concerns about CAM and risk than neurologists and general practitioners, based on negative consequences of patients' CAM use observed in their oncological practice. Those who were also trained in CAM expressed that most of CAM treatments are 'safe' and 'beneficial'. They were very aware, however, that some CAM treatments and unauthorized CAM practitioners could represent risk to patients, and they had been confronted with safety of CAM by other doctors who in their opinion needed more education in CAM to become more open-minded toward this topic.
Doctors had been trained to consider statistical risk figures when assessing clinical treatment options. In general, they perceived conventional medicine to be quality-assured, despite possible adverse effects:
'One benefit of working with these cancer patients (patients with lymphoma) is that we know from cancer statistics and clinical trials that their chances to get well if they use (certain conventional cancer treatments) are very good (…) Of course, this motivates us as doctors to try to motivate our patients to keep up with the possible adverse effects of the treatments'.
The doctors found clinical studies on CAM preparations and treatment regimens to be crucial for patients' safety. An oncologist explained:
'The problem with so many of these CAM preparations is that I don't know what they contain (…) What we have tried to do (in 2 cases where the oncologist thought that interaction between a conventional and a CAM treatment caused the death of the patient) was to notify The Norwegian Pharmacovigilance Advisory Board but they didn't want to hear about it because it (the CAM treatment) wasn't registered as a drug'. Some CAM therapies, e.g., acupuncture, were perceived as uncomplicated, whereas, e.g., cancer patients' use of St. John's wort and their treatment in certain unconventional clinics were perceived as risky. Several doctors had observed interactions between conventional treatments and CAM products: 'I have also seen several patients who have died -probably because they have combined our treatment with other drugs, or only taken other preparations. So it's -it's scary. ' The doctors described their risk assessments and risk communication in clinical encounters as heavily influenced by the acuteness and prognoses of the patients' disease. CAM use was not that problematic if the prognoses were positive or if there was no conventional treatment available. The oncologists had experienced dramatic consequences of delay or denial of conventional treatment in favor of CAM use in their practices:
'It turns out that the consequences of embracing one of those new age -a new outlook on life, in a way, maybe call it a philosophy of life -make you believe that the soul can heal almost anything, then you remove yourself really far from ... our kind of medicine. And then it ends up that a lot of them ... don't accept (conventional) treatment … Of course that is the major concern'. Delay or denial of essential conventional cancer or MS treatment was perceived as the overall risk associated with patients' use of CAM. The doctors said they felt frustrated and insecure when seriously ill patients do not trust in conventional medical approaches and thus choose CAM. They felt very responsible for their patients, who they defined as vulnerable, not only physically, but also psychologically and economically. The oncologists in particular found it difficult that they sometimes had no choice but to accept what they perceived as risky behavior. One said: 'Patients suffer in the name of freedom ... these are grown-ups, you knowin their right mind, and ... they have the full right to decide their treatment themselves. ' All doctors expressed the need for scientific risk evaluations of specific CAM therapies. They also stated that more knowledge about risk communication with users of CAM would be very helpful in clinical practice, as they had experienced situations where patients did not seem able to relate to medical information and medical risk perspectives.
Discussion
The analysis revealed fundamental differences between patients' and doctors' perspectives on risks and considerable challenges in risk communication. On the one hand, the patients often correlated potential adverse effects and use of conventional medicine; on the other hand, they perceived CAM therapies and products as being generally safe. The doctors perceived conventional treatments as quality-assured through scientific studies and thereby safe, whereas many CAM treatments were perceived as possibly harmful. This discussion will focus on interpretations of the differences between lay and medical risk perceptions and their possible implications.
Based on a sociocultural understanding of risk, risk perception and behavior can be seen as an important indicator of how laypersons and experts organize their social world [2] [3] [4] [5] [6] [7] [8] 17] . The empirical patterns revealed in this study suggest that contextual factors, scientific knowledge, individual knowledge and experience as well as instinctive reactions in stressful situations influence risk perceptions and risk behavior in different stakeholders. Many risk perceptions of CAM users can be interpreted as a result of subjective, lay constructions of risk, based on e.g. negative treatment experiences with conventional medicine in their social environment. The doctors' perceptions are examples of 'objective', scientific risk knowledge concerning direct risks, i.e. risk caused by the treatment itself and related directly to the intervention [44] . The encounter between patients' and doctors' risk perceptions can be perceived as 'risk as politics', involving power structures and knowledge systems within modern risk societies [45] . Particularly in stressful situations, lay people seem to use their positive and negative feelings as a guide to their evaluation of risks and benefits [45] [46] [47] . Patients have a need to understand their risk on an individual and personal level, while doctors often approach risk very analytically and logically; medical reality is encoded in abstract symbols, words, and numbers [2] [3] [4] [5] [6] [7] [8] [9] [44] [45] [46] [47] . In this study, patients' risk assessment was based on their own negative experiences with conventional health care and those perceived in their social environment. The risk assessment also depended on personally experienced effects of a treatment and whether it was scientifically evaluated. Perceived risk, trust, and uncertainty were closely connected in these patients' risk behavior. Recovery is often the main treatment goal among doctors, but several MS and cancer patients in this study perceived coping with illness and well-being in their everyday life as more realistic and important treatment goals, with CAM being a useful option to reach them. Peters and colleagues [9] describe 4 kinds of uncertainty that may exist in health care settings and result in patient strategies such as those revealed in this study: uncertainty about the magnitude or severity of possible benefits and risks, the strength of current evidence, how to weigh risks and benefits, and the likelihood of different outcomes.
The decision to use treatments outside the conventional health care can be linked to the politicization of health -returning control of one's health to the individual and control of the health system to the community. The flexible use of various sources of knowledge can afford considerable latitude for modern health care users in rating forms of evidence as authoritative and trustworthy [3, 9, [45] [46] [47] [48] . Prior [48] points out that laypersons are experts on experience basis, but that 'experience on its own is rarely sufficient to understand the technical complexities of disease causation, its consequences, and its management' [48, p 53] . Improved patient understanding of actual risk of illness recurrence or death is required in order to enable patients to make informed treatment decisions [9-10, 16, 22, 23] . However, although patients are often expected to understand consequences of treatment decisions that are justified by statistical numbers, they have either difficulties or refuse to accept this [4] [5] [45] [46] [47] . On the other hand, doctors often do not take into account the attitudes of patients towards risk-taking [3, 9, 10] , thus risk communication becomes very challenging for both parts.
This analysis leaves us with a key question: How can we handle differences in lay and medical understandings of risk, i.e. when 'our ancient instincts and our modern scientific analyses clash' [45, p. 21] , and consequently, patient safety may be threatened? Based on the results of this study, it seems to be essential to take into account that CAM users and doctors of conventional medicine have different risk perceptions. The basis for CAM users' decision-making, including their risk assessments, is often a complex construct of scientific and experience-based knowledge. This important information should be acknowledged in CAM research, health education, and clinical practice.
Methodological Aspects
The participants were recruited via the Registry of Exceptional Courses of Disease. The patients had reported 'exceptionally positive' courses of cancer and MS related to their use of CAM. No 'exceptionally negative' courses of MS and cancer have so far been reported to the Registry. It is likely that patients with negative experiences in the use of CAM will perceive CAM as a health risk, as is the case with negative reports from patients with other diagnoses in the Registry [49, 50] . However, most studies report positive user experiences from the widespread use of CAM [e.g., 13, 17, 19, [28] [29] [30] , and these CAM users need access to quality-assured risk information.
In order to exclude preconceived interpretations of patients' and doctors' risk perceptions [39] , a co-researcher from a larger qualitative study [28] [29] [30] and 2 patients and 1 doctor who participated in this study were consulted. To assess the quality of this study, we may ask whether our claims are supported by sufficient evidence. The results of this study cannot be generalized to populations of cancer or MS patients or transferred to other diagnostic groups. However, this study, as well as other studies on health consumers' lay theories, indicate that these theories are important factors in patients' decision-making processes [7, 17, [28] [29] [30] [45] [46] [47] and should be taken into account in both in-depth studies and large-sample, attitude-based surveys of risks associated with conventional medicine and CAM in the future.
Conclusion
This study revealed fundamental gaps in risk perceptions associated with the use of conventional medicine and CAM among MS and cancer patients and their doctors. These differences strongly influenced risk communication and patients' decision-making. While the patients perceived conventional medicine as potentially risky and CAM as safe, their doctors' perceptions were quite the contrary. CAM use tends to be widespread among MS and cancer patients and in Western populations in general, and divergent risk understandings may have far-reaching consequences for CAM users' decision-making and risk communication in clinical practice. CAM users need to be taken seriously as decision-makers based on their approaches to experiences, knowledge, and science. Thus, in clinical education and practice there should be a greater focus on differing risk perceptions and their possible implications for doctor-patient communication and patients' decision-making to strengthen patient safety in complex health societies characterized by uncertainty and therapeutic pluralism.
